论文部分内容阅读
肾综合症出血热(HFRS)又称流行性出血热,是由汉坦病毒引起的、以鼠类为传染源的一种自然疫源性疾病,临床表现为发热、出血、肾损害症状[1]。该病具有发病率高、病情凶险、死亡率高等特征,目前临床针对HFRS的治疗方法主要包括液体疗法、皮质激素疗法、止血抗凝疗法、抗病毒疗法、免疫疗法等,但究竟何种疗法为首选措施临床仍存在争议。为此,笔者选择以抗病毒治疗为主的药物利巴韦林、干扰素对患者进行了治疗,并取得了良好的疗效,现将治疗过程与结果报道如下。
Hemorrhagic fever with renal syndrome (HFRS), also known as epidemic hemorrhagic fever, is a natural foci disease caused by Hantavirus and infecting rodents. The clinical manifestations are fever, hemorrhage and renal damage [1 ]. The disease has the characteristics of high incidence, dangerous condition and high mortality. At present, the clinical treatment of HFRS mainly includes liquid therapy, corticosteroid therapy, hemostatic anticoagulation therapy, antiviral therapy and immunotherapy, but what kind of therapy is The preferred measures of clinical still controversial. To this end, I chose anti-virus therapy-based drugs ribavirin, interferon patients treated and achieved good results, now the treatment process and the results reported below.